Vitamin D to Improve Outcomes by Leveraging Early Treatment

PHASE3CompletedINTERVENTIONAL
Enrollment

1,358

Participants

Timeline

Start Date

April 27, 2017

Primary Completion Date

December 11, 2018

Study Completion Date

December 11, 2018

Conditions
Acute Respiratory Distress SyndromeVitamin D DeficiencyCritical Illness
Interventions
DRUG

Vitamin D3

540,000 IU vitamin D3 delivered as a single, liquid enteral dose administered either orally or via naso/orogastric tube

DRUG

Placebo

A single, liquid enteral dose identical in appearance and consistency to cholecalciferol administered either orally or via naso/orogastric tube.

Trial Locations (47)

10029

Mt. Sinai Hospital, New York

10467

Montefiore Medical Center, The Bronx

15261

UPMC Presbyterian/Mercy/Shadyside, Pittsburgh

17033

Penn State Hershey Medical Center, Hershey

22903

University of Virginia Health System, Charlottesville

23298

VCU Medical Center, Richmond

27157

Wake Forest Baptist Medical Center, Winston-Salem

37221

Vanderbilt University Medical Center, Nashville

39216

University of Mississippi Medical Center, Jackson

40506

University of Kentucky, Lexington

43203

OSU Hospital East Campus, Columbus

43210

Ohio State University Wexner Medical Center, Columbus

44195

Cleveland Clinic Foundation, Cleveland

44304

Summa Akron City Hospital, Akron

45219

University of Cincinnati Medical Center, Cincinnati

46202

IU Health Methodist Hospital, Indianapolis

48025

Henry Ford Medical Center, Detroit

48109

University of Michigan Medical Center, Ann Arbor

70112

University Medical Center, New Orleans

80045

Medical Center of Aurora, Aurora

University of Colorado Hospital, Aurora

80113

Swedish Medical Center, Englewood

80204

Denver Health Medical Center, Denver

80218

St. Joseph Hospital, Del Norte

84107

Intermountain Medical Center, Murray

84132

University of Utah Hospital, Salt Lake City

84143

LDS Hospital, Salt Lake City

84403

McKay-Dee Hospital, Ogden

84604

Utah Valley Regional Medical Center, Provo

90095

Ronald Reagan UCLA Medical Center, Los Angeles

93701

UCSF Fresno, Fresno

94143

UCSF Medical Center, San Francisco

94305

Stanford University, Stanford

95817

UC Davis Medical Center, Sacramento

97213

Providence Portland Medical Center, Portland

97239

Oregon Health and Science University, Portland

98104

Harborview Medical Center, Seattle

University of Washington Medical Center, Seattle

98122

Swedish Hospital Cherry Hill, Seattle

Swedish Hospital First Hill, Seattle

04102

Maine Medical Center, Portland

02111

Tufts Medical Center, Boston

02115

Brigham and Women's Hospital, Boston

02214

Massachusetts General Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

01199

Baystate Medical Center, Springfield

01608

St. Vincent's Hospital, Worcester

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Massachusetts General Hospital

OTHER

NCT03096314 - Vitamin D to Improve Outcomes by Leveraging Early Treatment | Biotech Hunter | Biotech Hunter